Clinical Trial Update: Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the combination of glucocorticoids, gamma globulin, and Ropristine N01 for initial severe primary immune thrombocytopenia; currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Gamma globulin (immunoglobulin)
• Glucocorticoid (glucocorticoid)
• Ropristine N01 (Ropristine N01)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Primary Immune Thrombocytopenia | Phase 2 | Status: RECRUITING